LIXTE BIOTECHNOLOGY HOLDINGS

LIXTNASDAQ

US Equity

$7.21▼ $0.46 (−6.00%)

Market closed · at close

Get earnings, price moves & breaking news on Telegram

24h▼ 6.0%

7d—

14d—

30d—

ytd▲ 83.9%

1y▲ 66.9%

🏦Market Cap

—

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

—

Insufficient data

Earnings

Q2 · 2026Reported 2026-05-14

Earnings Per Share

Actual

-0.18

Expected

—

—

—

YoY +37.90%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q2 2026

-0.18

—

Q1 2026

-0.33

—

Q4 2025

-0.33

—

Q3 2025

-0.29

—